A randomized double blind, placebo controlled study of risperidone in the treatment of DSM-IV-TR conduct disorder in children and adolescents

Trial Profile

A randomized double blind, placebo controlled study of risperidone in the treatment of DSM-IV-TR conduct disorder in children and adolescents

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Risperidone (Primary)
  • Indications Conduct disorder
  • Focus Therapeutic Use
  • Acronyms CONCA
  • Most Recent Events

    • 16 Apr 2014 New source identified and integrated (United Kingdom Clinical Research Network: 13994).
    • 20 Oct 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2011-000567-26).
    • 23 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top